| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Arcellx, Inc. (ACLX) has 5 insiders with recent SEC Form 4 filings, including 7 buys and 1 sell. ACLX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 782.5K | $90.04M | - | |
| CFO | 45.3K | $5.21M | - | |
| Other | 23.7K | $2.73M | - | |
| Dir | 2.7K | $311.4K | - | |
| Dir | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 13, 2022 | Heery Christopher48 | Chief Medical Officer | Sale+OE | 12,500 | $30.03 | $375,320.00 | -100% | -12.3% | +60.5% | |
| Jun 21, 2022 | New Enterprise Associates 15, L.P. | 10% Owner | Buy | 312,500 | $16.00 | $5,000,000.00 | +4.9% | +19.4% | +108.1% | |
| Feb 8, 2022 | New Enterprise Associates 15, L.P. | 10% Owner | Buy | 1,583,333 | $15.00 | $23,749,995.00 | +32.6% | -52.0% | +75.2% | |
| Feb 8, 2022 | Carroll Jill56 | Director | Buy | 1,666,667 | $15.00 | $25,000,005.00 | +43.5% | -52.0% | +75.2% | |
| Feb 8, 2022 | Sr One Capital Management, LLC52 | 10% Owner | Buy | 1,666,667 | $15.00 | $25,000,005.00 | +43.5% | -52.0% | +75.2% | |
| Feb 8, 2022 | Novo Holdings A/s58 | 10% Owner | Buy | 833,333 | $15.00 | $12,499,995.00 | +26.2% | -52.0% | +75.2% |